Clinical trial

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…

NCT00002984 · UNC Lineberger Comprehensive Cancer Center, Other · Completed

Key facts

NCT number NCT00002984
Title Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus
Official title Paclitaxel Combined With 5-FU and Cisplatin Concomitant With Radiotherapy in the Management of Locally Advanced or Metastatic Esophageal Cancer (Adenocarcinoma and Squamous Histologies) - A Phase I/Modified Phase II Trial
Lead sponsor UNC Lineberger Comprehensive Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Esophageal Cancer
Intervention type Drug, Procedure, Radiation
Interventions cisplatin, fluorouracil, paclitaxel, surgical procedure, radiation therapy
Enrollment 26
Start date Mar 1, 1997
Primary completion May 1, 2006
Completion Jan 1, 2007
First posted Jul 30, 2004
Last update posted May 24, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies